Clinical Trials Logo

Depression, Postpartum clinical trials

View clinical trials related to Depression, Postpartum.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06364436 Active, not recruiting - Clinical trials for PostPartum Depression

Distant Reiki Therapy on Postpartum Period Fatigue and Depression

Start date: June 3, 2022
Phase: N/A
Study type: Interventional

This research was conducted to evaluate the effect of Reiki therapy applied to women in the postpartum period on the risk of fatigue and postpartum depression.

NCT ID: NCT06246214 Active, not recruiting - Clinical trials for Depression, Postpartum

From Prevention to Treatment: How Biological Rhythms Can Maintain Perinatal Mental Health

Start date: January 4, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Depression and anxiety are significant public health issues during pregnancy and the postnatal period, particularly affecting those in developing countries. Disruptions in biological rhythms, sleep problems, and low exposure to daylight are associated with a higher risk of these mental health issues. The perinatal period poses unique challenges to the temporal program, with evidence indicating that sleep disturbances significantly increase the risk of postnatal depression. A Randomised Clinical Trial (RCT) is being conducted to assess the effectiveness of Blue Light Therapy (BlueLT) in treating depressive and anxiety symptoms during the postpartum. The RCT will also investigate the alignment of rest-activity and internal body time as mediating factors. This study will focus on various chronobiological factors, including rest-activity rhythms, light exposure levels, temperature rhythms, sleep duration and phase, social jetlag, and BodyTime (assessed through a single blood sample). The goal is to recruit 50 women with postpartum depression, with 25 in the BlueLT intervention group and 25 in the ControlLT placebo group, alongside 100 healthy controls. The BlueLT device uses a short-wavelength LED lamp mainly composed by a wavelength peak on blue spectrum, while the ControlLT device has a dim long-wavelength LED. A Healthy Control group will also be included to account for changes unrelated to depression diagnosis or placebo/treatment effects. Exclusion criteria involve a history of major depressive or anxiety disorder, current psychotic disorder, night shift work, active suicidal thoughts, unstable medical conditions interfering with data collection, and newborns with severe health conditions. The study aims to evaluate the impact of BlueLT on postpartum depression and understand the role of chronobiological factors in the health/disease process.

NCT ID: NCT05958095 Active, not recruiting - Clinical trials for PostPartum Depression

Curio Digital Therapy for the Treatment of Post-partum Depression

SuMMER
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Primary Objective: Evaluate the clinical effectiveness of the MamaLift Plus app compared to control (digital sham plus treatment as usual) for the management of PPD in the observed population for a period of 9 calendar weeks. It is hypothesized that women who use the MamaLift Plus APP will experience less severe symptoms of depression in post-partum period than comparable women who do not and receive their usual care from health providers.

NCT ID: NCT05894681 Active, not recruiting - Pregnancy Related Clinical Trials

Psychoeducation in Preventing Postpartum Depression According to Watson

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The postpartum period is marked by significant changes in a woman's priorities, roles, and responsibilities. It is a stressful transition period in which one faces physical and emotional challenges. This stressful transition period. It can seriously affect women's mental health and psychosocial well-being. postpartum depression (PPD) is a common complication in women. PPD in about one in seven women can develop. In addition, PPD is one of the leading causes of maternal morbidity and mortality. Preventive psychosocial and psychological practices are effective in reducing the incidence of PPD. cognitive behavioralist therapy, interpersonal psychotherapy and psychoeducational interventions are among these practices. Counseling, which is traditionally considered as a psychological intervention, is very useful for midwives and nurses. supports a number of theoretical applications and perspectives. Therefore, in order to achieve effective and beneficial results, education should be based on defined and organized theories and models. midwifery and nursing Implementation of care based on a model increases the success of care outcomes. health education Some models in the field allow us to explain the occurrence of behavior and its effect on a particular behavior. Helps us run the health education program to evaluate So about PPD A model selection is necessary for the conceptual framework of knowledge. The model chosen is the change in behavior. should explain their predictive factors and their effects on PPD. Health education in midwifery and nursing and One of the most frequently used models in the promotion of human care is Watson's Theory of Human Care (IBT). This model is love, It consists of the concepts of compassion, respect, trust and people and is a care that evaluates the individual as a whole provides. When the literature is examined, although there are a few studies aimed at preventing PPD, it is seen that PPD is It has been observed that there is no study on model-based psychoeducational intervention in the prevention of In our study, Watson model applied to pregnant women in the prevention of PPD was used to eliminate this deficiency aimed to evaluate the effect of a psychoeducational intervention based on

NCT ID: NCT05698394 Active, not recruiting - Clinical trials for Postpartum Depression

Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth

Start date: June 19, 2020
Phase: Phase 4
Study type: Interventional

Postpartum depression refers to the depression after childbirth, which is a common mental disorder in women. The pathogenesis of postpartum depression is not fully understood, and may be related to a variety of factors. Prenatal depression is an important risk factor for postpartum depression. Our recent multicenter randomized controlled trial, "Effect of Low-dose esketamine on the incidence of postpartum depression in women with prenatal depression", explored the effect of immediate postpartum intravenous infusion of low-dose esketamine on the incidence of postpartum depression in women with prenatal depression. The preliminary results showed that it reduced the incidence of postpartum depression at 42 days. Since there were no studies on the effect of intravenous esketamine infusion after delivery on long-term postpartum depression, this study is a long-term follow-up of the previous randomized trial. We aim to explore the effect of low-dose intravenous esketamine after delivery on the incidence of 2-year maternal depression after delivery in women with prenatal depressive symptoms.

NCT ID: NCT05484999 Active, not recruiting - Clinical trials for Postpartum Depression

The Maternal Well-Being Study

MWB
Start date: May 16, 2022
Phase: N/A
Study type: Interventional

This project aims to understand the local feasibility and acceptability of MamaMeals (a home-delivered nutritious, postpartum meal delivery program) and MamaMatters (a moderated social media-based peer support group) among peripartum women who are eligible for federal supplemental nutrition assistance programs such as The Special Supplemental Nutrition Program for Women, Infants and Children (WIC) or Supplemental Nutrition Assistance Program (SNAP). The investigators will conduct a prospective randomized controlled trial (RCT) of these two interventions among postpartum individuals. Analyses will be performed to determine the relative risk of postpartum depressive or anxiety symptoms (primary outcome) and overall well-being and maternal/infant health (secondary/exploratory outcomes) between groups. Findings from this pilot intervention study will inform a future, large RCT exploring the effectiveness of MamaMeals and/or MamaMatters on reducing postpartum mental health symptoms and cardiovascular morbidity among individuals with food insecurity during and after pregnancy.

NCT ID: NCT05353491 Active, not recruiting - Clinical trials for Depression, Postpartum

Thinking Healthy Program-Technology Assisted (THP-TA)

THP-TA
Start date: June 13, 2022
Phase: N/A
Study type: Interventional

Background The Thinking Healthy Program (THP) is an evidence based task-shifted low intensity psychosocial intervention, recommended by the World Health Organization for the treatment of perinatal depression. The investigators developed a technology-assisted version of Thinking Healthy Program (THP-TA) which allows peers to deliver the THP, while ensuring minimal resources for training of delivery agents and ensuring adequate fidelity. Method This is a non-inferiority, pragmatic cluster randomized controlled trial designed to test the primary hypothesis that technology assisted delivery of THP is not worse than THP intervention delivered by community health workers, in increasing perinatal depression remission rates at 3 months postnatal. In addition, this study will also test the effectiveness of the THP-TA in improving recovery from perinatal depression at 6 months postpartum, quality of life and social support. This study also aims to evaluate the cost-effectiveness of the THP-TA.

NCT ID: NCT05196152 Active, not recruiting - Clinical trials for Postpartum Depression

MomMoodBooster VA Program

Perinatal MMB
Start date: March 3, 2022
Phase: N/A
Study type: Interventional

The MomMoodBooster intervention is an empirically validated treatment for postpartum depression symptoms. The intervention was created by Brian Danaher and Milagra Tyler, who have continued to update the intervention technology and content. The intervention is now available for pregnant and postpartum Veterans, and it is accessible on browsers via computer, tablet, or mobile phone. The intervention contains six cognitive-behavioral modules that span six weeks, and it includes identification of pleasant activities, tracking mood and thoughts, and identification of goals. The current trial is an expansion of a nationwide service delivery project that has been ongoing for six years with the goal of offering the intervention to postpartum Veterans nationwide. Within that study, Veterans completed the online modules in concert with weekly phone coaching calls wherein coaches applied the content to the Veteran's current life. In addition, two booster modules and associated coaching calls were developed to continue application of the skills beyond the six-week intervention period. The present study seeks to investigate the incremental utility of the phone coaching component of the intervention by randomizing pregnant and postpartum Veterans to the MomMoodBooster intervention or the MomMoodBooster intervention plus phone coaching. Primary outcomes will include depressive symptoms, behavioral activation, and negative automatic thoughts.

NCT ID: NCT05110456 Active, not recruiting - Clinical trials for Depression, Postpartum

To Evaluate the Effectiveness of a Virtual and Telephone Intervention for the Prevention of Postpartum Depression in Women at Risk

Start date: November 9, 2021
Phase: N/A
Study type: Interventional

Women's perinatal mental health problems can create a cascade of short- and long-term negative influences for the mother, child, and the family as a whole. To prevent these impacts, preventive online and telephone interventions exist, but need to be tested and improved to develop this type of support to women in Quebec. The Parents & Babies program, which is a distance learning course, followed during pregnancy and accompanied by telephone follow-up, aims to improve the mental health of future parents.The investigators seek to evaluate the effect of the intervention of the Parents & Babies program offered with telephone support compared to the course offered without telephone follow-up.

NCT ID: NCT05044455 Active, not recruiting - Clinical trials for Postpartum Depression

Online Peer-Delivered Group CBT for PPD

Start date: March 28, 2022
Phase: N/A
Study type: Interventional

Mothers and birthing parents (hereafter referred to as mothers) who have recovered from Postpartum Depression and are well now, receive training to teach a 9 week Cognitive Behavioural Therapy (CBT) treatment to mothers who are feeling depressed after giving birth in the last year. Eligible mothers are randomly assigned to one of two groups. Mothers in one group will receive a 9 week group CBT intervention delivered online by the trained Peer facilitators. Mothers in the other group will not receive the CBT group intervention and will continue to receive treatment as usual or regular care for new mothers. Mothers in both groups will complete online questionnaires three times - when participants start the study, nine weeks later and six months after that. Mothers in the intervention group will also complete a few questionnaires once during the intervention and a satisfaction questionnaire at end of intervention. Participant information will help determine if the CBT treatment is helpful for postpartum depression.